Amy Jamieson

1.0k total citations
39 papers, 401 citations indexed

About

Amy Jamieson is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy Jamieson has authored 39 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Obstetrics and Gynecology, 17 papers in Reproductive Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy Jamieson's work include Endometrial and Cervical Cancer Treatments (25 papers), Ovarian cancer diagnosis and treatment (16 papers) and Sarcoma Diagnosis and Treatment (11 papers). Amy Jamieson is often cited by papers focused on Endometrial and Cervical Cancer Treatments (25 papers), Ovarian cancer diagnosis and treatment (16 papers) and Sarcoma Diagnosis and Treatment (11 papers). Amy Jamieson collaborates with scholars based in Canada, Finland and United States. Amy Jamieson's co-authors include Jessica N. McAlpine, Tjalling Bosse, Emily F. Thompson, Jutta Huvila, C. Blake Gilks, C. Blake Gilks, Samuel Leung, Amy Lum, Janine Senz and David G. Huntsman and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Amy Jamieson

32 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy Jamieson Canada 12 277 174 86 77 71 39 401
Giulia Scaglione Italy 10 268 1.0× 214 1.2× 76 0.9× 82 1.1× 106 1.5× 58 434
Nicoletta D’Alessandris Italy 14 329 1.2× 242 1.4× 86 1.0× 92 1.2× 110 1.5× 53 487
Mary Kinloch Canada 7 247 0.9× 191 1.1× 80 0.9× 69 0.9× 39 0.5× 18 365
Matthew Cesari Canada 10 416 1.5× 332 1.9× 88 1.0× 125 1.6× 63 0.9× 19 529
Eman Abdulfatah United States 10 150 0.5× 117 0.7× 54 0.6× 36 0.5× 45 0.6× 31 306
Britta Nordström Sweden 9 251 0.9× 185 1.1× 52 0.6× 70 0.9× 63 0.9× 20 376
M. Lapresa Italy 10 199 0.7× 294 1.7× 44 0.5× 29 0.4× 113 1.6× 16 420
Oisín Houghton United Kingdom 8 118 0.4× 104 0.6× 35 0.4× 83 1.1× 54 0.8× 13 306
Michaela Bártů Czechia 11 104 0.4× 125 0.7× 60 0.7× 36 0.5× 112 1.6× 52 385
Ilaria Cuccu Italy 9 132 0.5× 125 0.7× 51 0.6× 34 0.4× 92 1.3× 20 283

Countries citing papers authored by Amy Jamieson

Since Specialization
Citations

This map shows the geographic impact of Amy Jamieson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Jamieson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Jamieson more than expected).

Fields of papers citing papers by Amy Jamieson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Jamieson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Jamieson. The network helps show where Amy Jamieson may publish in the future.

Co-authorship network of co-authors of Amy Jamieson

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Jamieson. A scholar is included among the top collaborators of Amy Jamieson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Jamieson. Amy Jamieson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jamieson, Amy, Jutta Huvila, Samuel Leung, et al.. (2025). Co-existent endometrial and ovarian carcinoma: molecular and pathological features define low risk entity. International Journal of Gynecological Cancer. 35(8). 101957–101957.
2.
Martin, Spencer D., Christine S. Chow, Katy Milne, et al.. (2025). Activated immune infiltrates expand opportunities for targeted therapy in p53‐abnormal endometrial carcinoma. The Journal of Pathology. 266(3). 292–305. 3 indexed citations
4.
Höhn, Anne Kathrin, Benjamin Wolf, Christine Brambs, et al.. (2025). Trop2 Expression in Correlation to the Molecular Subtype in Vulvar Squamous Cell Carcinomas. Pathobiology. 92(3). 150–156. 2 indexed citations
5.
6.
Farahani, Hossein, Maryam Asadi, Matthew O. Wiens, et al.. (2024). AI-based histopathology image analysis reveals a distinct subset of endometrial cancers. Nature Communications. 15(1). 4973–4973. 13 indexed citations
7.
Jamieson, Amy, Marcel Grube, Samuel Leung, et al.. (2024). Recurrence rates and patterns of recurrence in stage IA p53abn endometrial cancer with and without myometrial invasion. International Journal of Gynecological Cancer. 34(4). 544–549. 5 indexed citations
8.
Huvila, Jutta, Amy Jamieson, Jennifer Pors, et al.. (2024). Endometrial Carcinosarcomas are Almost Exclusively of p53abn Molecular Subtype After Exclusion of Mimics. International Journal of Gynecological Pathology. 43(5). 506–514. 11 indexed citations
9.
Horn, Lars‐Christian, Christine Brambs, C. Blake Gilks, et al.. (2024). Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild Type. Cancers. 16(24). 4216–4216. 3 indexed citations
10.
Hoang, Lynn, Brooke E. Howitt, Teri A. Longacre, et al.. (2024). The spectrum of oestrogen receptor expression in endometrial carcinomas of no specific molecular profile. Histopathology. 85(4). 660–670. 6 indexed citations
11.
Pors, Jennifer, Amy Lum, Samuel Leung, et al.. (2024). Papillary and ductal patterns of mesonephric‐like adenocarcinomas are often overlooked: a retrospective revaluation of over 1000 endometrial carcinomas. Histopathology. 86(6). 862–877. 2 indexed citations
12.
Jamieson, Amy, Dawn R. Cochrane, J. Maxwell Douglas, et al.. (2024). Targeted and Shallow Whole-Genome Sequencing Identifies Therapeutic Opportunities in p53abn Endometrial Cancers. Clinical Cancer Research. 30(11). 2461–2474. 11 indexed citations
13.
Jamieson, Amy, et al.. (2023). Surgical management of intravenous leiomyomatosis with intracardiac extension. Journal of Vascular Surgery Cases and Innovative Techniques. 9(4). 101302–101302.
14.
Huvila, Jutta, Emily F. Thompson, Amy Lum, et al.. (2023). Subclonal p53 immunostaining in the diagnosis of endometrial carcinoma molecular subtype. Histopathology. 83(6). 880–890. 17 indexed citations
15.
Jamieson, Amy, Melissa K. McConechy, Amy Lum, et al.. (2023). Harmonized molecular classification; assessment of a single-test ProMisE NGS tool. Gynecologic Oncology. 175. 45–52. 14 indexed citations
16.
Thompson, Emily F., Richard Wing-Cheuk Wong, Basile Tessier‐Cloutier, et al.. (2023). p53-Abnormal “Fields of Dysplasia” in Human Papillomavirus–Independent Vulvar Squamous Cell Carcinoma Impacts Margins and Recurrence Risk. Modern Pathology. 36(2). 100010–100010. 8 indexed citations
17.
Jamieson, Amy, Lisa Barroilhet, & Jessica N. McAlpine. (2022). Molecular classification in endometrial cancer: Opportunities for precision oncology in a changing landscape. Cancer. 128(15). 2853–2857. 15 indexed citations
18.
Talhouk, Aline, Amy Jamieson, Emma J. Crosbie, et al.. (2022). Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol. International Journal of Gynecological Pathology. 42(4). 353–363. 16 indexed citations
19.
Thompson, Emily F., Richard Wing-Cheuk Wong, Janine Senz, et al.. (2022). Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma. International Journal of Gynecological Cancer. 32(10). 1229–1235. 6 indexed citations
20.
Thompson, Emily F., Lynn Hoang, Anne Kathrin Höhn, et al.. (2022). Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique. International Journal of Gynecological Cancer. 32(8). 977–985. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026